Tapinarof
Sponsors
Organon and Co, Wake Forest University Health Sciences, Psoriasis Treatment Center of Central New Jersey, Indiana University, Northwestern University
Conditions
Atopic DermatitisCutaneous Lupus ErythematosusICD10 Code L40.9 for PsoriasisPalmoplantar KeratodermaPlaque PsoriasisPsoriasis
Early Phase 1
Phase 2
Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
Enrolling by invitationNCT05981118
Start: 2024-07-15End: 2026-12-31Target: 40Updated: 2025-12-17
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
RecruitingNCT06561321
Start: 2024-10-30End: 2027-12-31Target: 6Updated: 2026-03-04